Australia Markets closed

Why I would invest $20,000 into these top ASX shares

James Mickleboro
business leader making money

If you’re lucky enough to have $20,000 to invest in the share market, then listed below are three shares I would consider buying with these funds.

I believe all have strong growth potential and could generate outsized returns for investors over the next decade. Here’s why I rate them highly:

Cochlear Limited (ASX: COH)

I think that Cochlear would be a great option for these funds. I continue to believe the hearing solutions company is one of the best buy and hold options on the local share market. This is due to it being well-positioned for strong long term growth thanks to the ageing populations tailwind. By 2050 there are forecast to be 1.5 billion people over the aged of 65. This will be almost triple the number of over 65s in 2010. I expect this tailwind to drive a sustained increase in demand for its cochlear implantable devices over the next few decades.

Nearmap Ltd (ASX: NEA) 

The Nearmap share price has been a very disappointing performer in 2020. Due to a surprise guidance downgrade, the aerial imagery technology and location data company’s shares have come under significant pressure. Whilst the downgrade was disappointing, I think the selloff has been severely overdone and has left its shares trading at a very attractive level. In light of this, I think it could be worth considering a long-term focused investment in Nearmap’s shares. Especially given its positive long-term outlook thanks to its sizeable market opportunity and high quality product offering.

Xero Limited (ASX: XRO)

Another share to consider investing that $20,000 into could be Xero. I think the cloud-based business and accounting software provider could be a great long-term investment option due to its strong growth potential. This is thanks to the opportunity that its high quality software has to become the platform of choice for small and medium sized businesses across the globe. If it achieves this, it should support above-average sales growth for a long time to come.

The post Why I would invest $20,000 into these top ASX shares appeared first on Motley Fool Australia.

And if you have more funds leftover to invest, I think these hot stocks could be great options right now.

NEW. 5 Best Stocks to Buy….

Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Another is a diversified conglomerate trading near a 52-week low all while offering a 2.7% fully franked yield...

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

CLICK HERE FOR YOUR FREE REPORT!

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and Xero. The Motley Fool Australia owns shares of and has recommended Nearmap Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2020